Exact Sciences Corporation Stock Mexican S.E.
Stocks
EXAS *
US30063P1057
Biotechnology & Medical Research
| Market Cap | 20.03B 344B 17.3B 15.94B 14.92B 27.96B 1,903B 28.39B 188B 73.38B 927B 75.16B 73.56B 3,208B | P/E Ratio 2024 |
-10.1x | P/E Ratio 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.6B 371B 18.65B 17.19B 16.09B 30.15B 2,053B 30.62B 203B 79.13B 999B 81.05B 79.32B 3,460B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Exact Sciences Corporation
| 1 day | -15.23% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.23% | +9.18% | - | - | 20.03B | |
| -0.19% | -2.87% | +79.01% | +75.36% | 3.78B | |
| -6.03% | +4.14% | +70.54% | +100.46% | 2.82B | |
| +4.05% | -2.03% | -31.58% | -39.75% | 1.94B | |
| +3.03% | -3.55% | +82.14% | -53.85% | 1.82B | |
| -2.92% | +3.24% | +23.56% | +174.76% | 1.19B | |
| -0.36% | -6.03% | -13.29% | +15.43% | 853M | |
| -0.72% | -22.50% | +92.46% | - | 782M | |
| -4.41% | -0.80% | +133.80% | -65.98% | 735M | |
| +0.66% | -4.95% | -28.20% | -15.87% | 540M | |
| Average | -2.21% | -1.15% | +45.38% | +23.82% | 1.61B | |
| Weighted average by Cap. | -9.18% | -0.54% | +52.41% | +40.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 47.45B 2.38B 2.2B 2.06B 3.85B 262B 3.91B 25.93B 10.11B 128B 10.35B 10.13B 442B | 3.25B 55.84B 2.8B 2.58B 2.42B 4.53B 309B 4.6B 30.51B 11.9B 150B 12.19B 11.93B 520B |
| Net income | -1.03B -17.7B -889M -819M -766M -1.44B -97.79B -1.46B -9.67B -3.77B -47.6B -3.86B -3.78B -165B | -208M -3.58B -180M -166M -155M -290M -19.77B -295M -1.95B -762M -9.62B -780M -764M -33.31B |
| Net Debt | 1.74B 29.89B 1.5B 1.38B 1.29B 2.43B 165B 2.46B 16.33B 6.37B 80.39B 6.52B 6.38B 278B | 1.57B 27B 1.36B 1.25B 1.17B 2.19B 149B 2.23B 14.76B 5.75B 72.64B 5.89B 5.77B 252B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
